PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 63 filers reported holding PLX PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,149,000 | +145.0% | 143,459 | +322.5% | 0.00% | – |
| Q2 2021 | $469,000 | +182.5% | 33,956 | +84.7% | 0.00% | – |
| Q1 2021 | $166,000 | +95.3% | 18,382 | +19.9% | 0.00% | – |
| Q4 2020 | $85,000 | -33.6% | 15,326 | -61.2% | 0.00% | – |
| Q3 2020 | $128,000 | -0.8% | 39,550 | -2.8% | 0.00% | – |
| Q2 2020 | $129,000 | +37.2% | 40,707 | -2.2% | 0.00% | – |
| Q1 2020 | $94,000 | -47.5% | 41,618 | +1.6% | 0.00% | – |
| Q4 2019 | $179,000 | -32.5% | 40,948 | -21.2% | 0.00% | – |
| Q3 2019 | $265,000 | -26.2% | 51,963 | +4.1% | 0.00% | -100.0% |
| Q2 2019 | $359,000 | +31.0% | 49,913 | -4.5% | 0.00% | – |
| Q1 2019 | $274,000 | +211.4% | 52,275 | -8.6% | 0.00% | – |
| Q4 2018 | $88,000 | -74.8% | 57,213 | -33.6% | 0.00% | – |
| Q3 2018 | $349,000 | – | 86,209 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 1,875,000 | $4,556,000 | 0.28% |
| Ground Swell Capital, LLC | 48,931 | $119,000 | 0.22% |
| Park West Asset Management LLC | 1,473,218 | $3,580,000 | 0.20% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 62,673 | $152,000 | 0.07% |
| Eidelman Virant Capital | 27,000 | $63,000 | 0.04% |
| MBL Wealth, LLC | 52,000 | $126 | 0.03% |
| O'Brien Greene & Co. Inc | 22,340 | $54,000 | 0.02% |
| SHUFRO ROSE & CO LLC | 56,800 | $138,000 | 0.01% |
| GW&K Investment Management, LLC | 424,921 | $1,033,000 | 0.01% |
| EXANE DERIVATIVES | 6,575 | $15,974,000 | 0.01% |